Seattle Genetics is committed to supporting innovative, high quality medical education for healthcare professionals that addresses unmet medical needs, fosters clinical excellence and improves health outcomes.

Roche strives to address unmet medical needs through excellence in Science. Spreading breakthroughs in science and technology allows HCP to find out precisely what is malfunctioning in the body and contributes to generate new questions to be answered. We are committed to support Medical Education as it is the driving force of excellence in Science. We are Roche.

At Gilead, we’re committed to creating a healthier world for everyone – no matter the challenges ahead of us. For more than 30 years, we’ve pursued the impossible, chased it down, tackled it for answers and surrounded it for a way in. We have worked tirelessly to bring forward medicines for life-threatening diseases.

Through bold and transformative science, we’re driving innovation that has the potential to become the next generation of life-changing medicines. Our ambition is evident in our mission. Because the impossible is not impossible. It’s what’s next.

Menarini Stemline is a pharmaceutical company that is part of the Menarini Group, with an exclusive focus on research and development of innovative therapies in oncology and onco-haematology. Among our objectives is to work with all healthcare institutions, scientific societies, academic institutions and patient associations in order to improve the lives of people with cancer in Spain. To this end, our commitment to the continuous training and updating of healthcare professionals is fundamental, which is key to the excellence in patient care offered by the National Health System. To this end, we support some of the leading medical education initiatives developed by the leading oncology and onco-haematology organizations in our country.

At Lilly, our commitment to medical education and training of oncology professionals is critical to advancing cancer treatment. Through training programs and collaborations with scientific groups like SOLTI, we seek to provide access to cutting-edge knowledge and tools that help healthcare professionals improve the lives of their patients. Together, we continue to drive innovation and excellence in cancer care.